RGL Revenue and Competitors

Cherry Creek, CO USA

Location

N/A

Total Funding

Accounting

Industry

Estimated Revenue & Valuation

  • RGL's estimated annual revenue is currently $26.4M per year.(i)
  • RGL's estimated revenue per employee is $179,300

Employee Data

  • RGL has 147 Employees.(i)
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.8M373%N/AN/A
#2
$16.5M10113%N/AN/A
#3
$29.6M165-8%N/AN/A
#4
$0.7M90%N/AN/A
#5
$6M46-4%N/AN/A
#6
$6M462%N/AN/A
#7
$26.4M147N/AN/AN/A
#8
$4.6M359%N/AN/A
#9
$5.2M400%N/AN/A
#10
$33.2M18520%N/AN/A
Add Company

RGL provides expert, independent assessments of value - as it pertains to the past, present or future - for use in business planning, financing, disputes, agreements, contracts and settlements, whether or not within the context of litigation. In complex business appraisals we determine what drives real business value and use our investigative accounting skills to see through the numbers. We are experts at dealing with the big picture as well as the details, and are intimately familiar with the rules and regulations that govern the appraisal process.

keywords:N/A

N/A

Total Funding

147

Number of Employees

$26.4M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

RGL News

2022-04-17 - Comment on “Impact of neurodegenerative diseases on ...

In addition, a small population of RGL progenitors should exhibit high levels of proliferation to produce such levels of neurogenesis. However,...

2022-04-06 - Riversgold (ASX:RGL) confirms lithium mineralisation potential at Tambourah

Riversgold (RGL) confirms the potential for extensive lithium mineralisation at the Tambourah lithium project in WA's Pilbara region...

2022-03-22 - RAP, RGL and NOX - Three ASX penny stocks delivering massive gains today

Highlights. The ASX Small Ordinaries index was seen 0.49% up at 3,293.2, by 12:30 PM AEDT. RAP, RGL and NOX were...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$25M157-12%N/A
#2
$38.2M158N/AN/A
#3
$37M1601%N/A
#4
$45M1611%N/A
#5
$41M164-7%N/A